Clinical Trial: Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A 1-Year Open-Label Safety Extension Study of Pregabalin in Patients With Anxiety Disorders

Brief Summary: Determine long-term safety and tolerability of pregabalin in patients with anxiety disorders.

Detailed Summary:
Sponsor: Pfizer

Current Primary Outcome: Safety Tolerability

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Pfizer

Dates:
Date Received: September 6, 2005
Date Started: January 2001
Date Completion: March 2006
Last Updated: July 13, 2006
Last Verified: July 2006